학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 197건 | 목록 20~30
Academic Journal
Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. eterpos@med.uoa.gr.; Engelhardt M; Faculty of Freiburg, Hematology and Oncology Department, Interdisciplinary Cancer Center (ITZ) and Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Freiburg, Germany.; Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals National Health Service Trust and University of Leeds, Leeds, UK.; Gay F; Division of Hematology, University of Turin, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.; Mateos MV; Cancer Research Unit, University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Institute of Cancer Molecular and Cellular Biology (USAL-CSIC), Centre for Cancer Research (IBMCC), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; van de Donk NWCJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Avet-Loiseau H; Genomics of Myeloma Laboratory, L'Institut Universitaire du Cancer Oncopole, Toulouse, France.; Hajek R; Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Vangsted AJ; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Ludwig H; Wilhelminen Cancer Research Institute, c/o Department of Medical Oncology, Hematology and Palliative Care, Wilhelminenspital Wien, Austria.; Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Moreau P; Department of Hematology, University Hospital Hotel-Dieu, Nantes, France.; Einsele H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.; Boccadoro M; Division of Hematology, University of Turin, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.; San Miguel J; Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain.; Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Caballero-Velázquez T; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.; Calderón-Cabrera C; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.; López-Corral L; Department of Hematology, Complejo Asistencial Universitario de Salamanca-IBSAL-CIBERONC, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; Puig N; Department of Hematology, Complejo Asistencial Universitario de Salamanca-IBSAL-CIBERONC, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; Marquez-Malaver F; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.; Pérez-López E; Department of Hematology, Complejo Asistencial Universitario de Salamanca-IBSAL-CIBERONC, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; García-Calderón C; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.; Rosso-Fernández CM; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.; Caballero Barrigón D; Department of Hematology, Complejo Asistencial Universitario de Salamanca-IBSAL-CIBERONC, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; Martín J; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.; Mateos MV; Department of Hematology, Complejo Asistencial Universitario de Salamanca-IBSAL-CIBERONC, Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; San Miguel J; Clínica Universidad de Navarra, Centro Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona, Spain.; Pérez-Simón JA; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain. josea.perez.simon.sspa@juntadeandalucia.es.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Report
Sanoja-Flores L; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service (NUCLEUS) and.; Department of Medicine, University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Flores-Montero J; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service (NUCLEUS) and.; Department of Medicine, University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Puig N; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Department of Hematology and.; Contreras-Sanfeliciano T; Department of Biochemistry, University Hospital of Salamanca, Salamanca, Spain.; Pontes R; Department of Pediatrics, Institute of Pediatrics and Puericulture Martagão Gesteira (IPPMG) and.; Corral-Mateos A; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service (NUCLEUS) and.; Department of Medicine, University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; García-Sánchez O; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Department of Hematology and.; Díez-Campelo M; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Department of Hematology and.; Pessoa de Magalhães RJ; University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.; García-Martín L; Department of Hematology, Hospital of Zamora, Zamora, Spain.; Alonso-Alonso JM; Department of Hematology, Hospital of Palencia, Palencia, Spain.; García-Mateo A; Department of Hematology, Hospital of Segovia, Segovia, Spain.; Aguilar-Franco C; Department of Hematology, Hospital of Soria, Soria, Spain.; Labrador J; Department of Hematology, Hospital of Burgos, Burgos, Spain.; Barez-García A; Department of Hematology, Hospital of Ávila, Ávila, Spain.; Maiolino A; University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.; Paiva B; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Clinica Universidad de Navarra, Applied Medical Research Center (CIMA), IDISNA, Pamplona, Spain.; San Miguel J; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Clinica Universidad de Navarra, Applied Medical Research Center (CIMA), IDISNA, Pamplona, Spain.; Sobral da Costa E; Department of Pediatrics, Institute of Pediatrics and Puericulture Martagão Gesteira (IPPMG) and.; González M; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Department of Hematology and.; Mateos MV; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.; Department of Hematology and.; Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA; and.; van Dongen JJM; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Orfao A; Cancer Research Center-Instituto de Biología Celular y Molecular del Cáncer (IBMCC) of the Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service (NUCLEUS) and.; Department of Medicine, University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Instituto Carlos III, Madrid, Spain.; Instituto de Investigación Biosanitaria (IBSAL), Salamanca, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Mateos MV; Complejo Asistencial Universitario de Salamanca/IBSAL, Salamanca, Spain. Electronic address: mvmateos@usal.es.; Blacklock H; Middlemore Hospital, Auckland, New Zealand.; Schjesvold F; Oslo Myeloma Center, Oslo University Hospital and KG Jebsen Center for B-Cell Malignancies, University of Oslo, Oslo, Norway.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Triasi Pujol, Barcelona, Spain.; Simpson D; North Shore Hospital, Auckland, New Zealand.; George A; Wellington Blood and Cancer Center, Wellington, New Zealand.; Goldschmidt H; University Hospital Heidelberg and National Center of Tumor Diseases in Heidelberg, Heidelberg, Germany.; Larocca A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.; Chanan-Khan A; Mayo Clinic, Jacksonville, FL, USA.; Sherbenou D; University of Colorado Cancer Center, Denver, CO, USA.; Avivi I; Sourasky Medical Center, Haifa, Israel.; Benyamini N; Rambam Health Care Campus, HaAliya HaShniya, Israel.; Iida S; Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Japan.; Matsumoto M; National Hospital Organization, Shibukawa Medical Center, Shibukawa, Gunma, Japan.; Suzuki K; Japanese Red Cross, Tokyo, Japan.; Ribrag V; Institut Gustave Roussy, Villejuif, France.; Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.; Jagannath S; The Mount Sinai Medical Hospital, New York, NY, USA.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.; Rodriguez-Otero P; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.; San Miguel J; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.; Kher U; Merck & Co, Kenilworth, NJ, USA.; Farooqui M; Merck & Co, Kenilworth, NJ, USA.; Liao J; Merck & Co, Kenilworth, NJ, USA.; Marinello P; Merck & Co, Kenilworth, NJ, USA.; Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Academic Journal
Richardson PG; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: paul_richardson@dfci.harvard.edu.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.; Beksac M; Ankara University, Ankara, Turkey.; Liberati AM; Università degli studi di Perugia, Perugia, Italy.; Galli M; Azienda Ospedaliera Papa Giovanni XXIII, Unità Operativa di Ematologia, Bergamo, Italy.; Schjesvold F; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway; K G Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.; Lindsay J; East Kent Hospitals University NHS Foundation Trust, Kent and Canterbury Hospital, Canterbury, UK.; Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; White D; Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.; Facon T; University of Lille, Centre Hospitalier Universitaire Lille, Service des Maladies du Sang, Lille, France.; San Miguel J; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.; Sunami K; National Hospital Organization Okayama Medical Center, Okayama, Japan.; O'Gorman P; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland; Cancer Trials Ireland, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.; Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Robak P; Medical University of Lodz, Lodz, Poland.; Semochkin S; Pirogov Russian National Research Medical University, Moscow, Russia.; Schey S; Department of Hematology, King's College London, London, UK.; Yu X; Celgene Corporation, Summit, NJ, USA.; Doerr T; Celgene Corporation, Summit, NJ, USA.; Bensmaine A; Celgene International, Boudry, Switzerland.; Biyukov T; Celgene International, Boudry, Switzerland.; Peluso T; Celgene International, Boudry, Switzerland.; Zaki M; Celgene Corporation, Summit, NJ, USA.; Anderson K; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Dimopoulos M; National and Kapodistrian University of Athens, Athens, Greece.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Hillengass J; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: jens.hillengass@roswellpark.org.; Usmani S; Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC, USA.; Rajkumar SV; Division of Hematology, Department of Internal Medicine and Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Durie BGM; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, USA.; Mateos MV; Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain.; Lonial S; Emory University Medical School, Atlanta, GA, USA.; Joao C; Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.; Anderson KC; Dana-Farber Cancer Institute, Boston, MA, USA.; García-Sanz R; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Riva E; Department of Hematology, Hospital de Clinicas, Montevideo, Uruguay.; Du J; Department of Hematology, Changzhen Hospital, Shanghai, China.; van de Donk N; VU University Medical Center Amsterdam, Amsterdam, Netherlands.; Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.; Terpos E; Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.; Zamagni E; University of Bologna, Bologna, Italy.; Kyle RA; Department of Laboratory Medecine and Pathology, Mayo Clinic, Rochester, MN, USA.; San Miguel J; Clinica Universitaria de Navarra, CIMA, Pamplona, Spain.; Goldschmidt H; University Hospital Heidelberg, National Center for Tumor diseases Heidelberg, Heidelberg, Germany.; Giralt S; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Kumar S; Department of Hematology, Mayo Clinic, Rochester, MN, USA.; Raje N; Department of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.; Ludwig H; Department of Medicine I, Wilhelminenspital Der Stadt Wien, Vienna, Austria.; Ocio E; Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain.; Schots R; Department of Clinical Hematology, Universitair Ziekenhuis Brussel, Brussels, Belgium.; Einsele H; Universitätsklinik Würzburg, Würzburg, Germany.; Schjesvold F; Oslo Myeloma Center, Oslo University Hospital; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.; Chen WM; Department of Hematology and Oncology, Beijing Chaoyang Hospital, Beijing, China.; Abildgaard N; Department of Hematology, Syddansk Universitet, Odense, Denmark.; Lipe BC; Departments of Medicine and Hematology and Oncology, University of Rochester, Rochester, NY, USA.; Dytfeld D; Karol Marcinkowski University of Medical Sciences, Poznan, Poland.; Wirk BM; Department of Hematology and Oncology, Boston University, Boston, MA, USA.; Drake M; Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine and Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Cavo M; University of Bologna, Bologna, Italy.; Lahuerta JJ; Department of Hematology, Grupo Español di Mieloma, Hospital Universitario, Madrid, Spain.; Lentzsch S; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY, USA.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Walker BA; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Mavrommatis K; Celgene Corporation, San Francisco, CA, USA.; Wardell CP; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Ashby TC; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Bauer M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Davies F; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Rosenthal A; Cancer Research and Biostatistics, Seattle, WA, USA.; Wang H; Cancer Research and Biostatistics, Seattle, WA, USA.; Qu P; Cancer Research and Biostatistics, Seattle, WA, USA.; Hoering A; Cancer Research and Biostatistics, Seattle, WA, USA.; Samur M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Towfic F; Celgene Corporation, Summit, NJ, USA.; Ortiz M; Celgene Institute of Translational Research Europe, Sevilla, Spain.; Flynt E; Celgene Corporation, Summit, NJ, USA.; Yu Z; Celgene Corporation, Summit, NJ, USA.; Yang Z; Celgene Corporation, Summit, NJ, USA.; Rozelle D; Rancho BioSciences, San Diego, CA, USA.; Obenauer J; Rancho BioSciences, San Diego, CA, USA.; Trotter M; Celgene Institute of Translational Research Europe, Sevilla, Spain.; Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT, USA.; Keats J; Translational Genomics Research Institute, Phoenix, AZ, USA.; Bolli N; University of Milan, Milano, Italy.; Fulciniti M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Szalat R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Moreau P; University of Nantes, Nantes, France.; Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, USA.; Stewart AK; Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA.; Goldschmidt H; Department of Medicine V, Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.; Raab MS; Department of Medicine V, Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Heidelberg, Germany.; Einsele H; Department of Internal Medicine II, Wurzburg University, Wurzburg, Germany.; Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; San Miguel J; Clinica Universidad de Navarra, Centro Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona, Spain.; Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Jackson GH; Department of Haematology, Newcastle University, Newcastle, UK.; Anderson KC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Avet-Loiseau H; Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé et de la Recherche Médicale, U1037, Toulouse, France.; L'Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire, Toulouse, France.; Munshi N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Thakurta A; Celgene Corporation, Summit, NJ, USA.; Morgan G; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. GJMorgan@uams.edu.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Lopez-Anglada L; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Madrid, Spain.; Cueto-Felgueroso C; Clinical Biochemistry Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Rosiñol L; Hematology Department, Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Oriol A; Hospital Germans i Trials, Barcelona, Spain.; Teruel AI; Hematology Department, Hospital Clínico de Valencia, Valencia, Spain.; Lopez de la Guia A; Hematology Department, Hospital La Paz, Madrid, Spain.; Bengoechea E; Hematology Department, Hospital de Donostia, San Sebastian, Spain.; Palomera L; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; de Arriba F; Hospital Morales Meseguer, Murcia, Spain.; Hernandez JM; Hematology Department, Hospital General de Segovia, Segovia, Spain.; Granell M; Haematology, Hospital Univarsitari de la Santa Creu i Sant Pau, Barcelona,Spain.; Peñalver FJ; Haematology Department, Hospital Universitario Fundacion Alcorcon, Madrid, Spain.; Garcia-Sanz R; Hematology Department, Hospital Universitario de Salamanca-IBSAL, IBMCC-CSIC, Salamanca, Spain.; Besalduch J; Haematology Department, Hospital Univarsitari Son Espases, Mallorca, Spain.; Gonzalez Y; Haematology Department, Institutd'Oncologia Dr Josep Trueta de Girona, Girona, Spain.; Martinez RB; Haematology Department, Hospital Universitario San Carlos, Madrid, Spain.; Hernandez MT; Haematology Department, Hospital Universitario de Canarias, Tenerife, Spain.; Gutierrez NC; Hematology Department, Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Puerta P; Clinical Biochemistry Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Valeri A; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Madrid, Spain.; Paiva B; Haematology Department, Clínica Universitaria de Navarra/ CIMA,IDISNA, CIBERONC,Pamplona, SPAIN.; Blade J; Hospital Germans i Trials, Barcelona, Spain.; Mateos MV; Hematology Department, Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; San Miguel J; Haematology Department, Clínica Universitaria de Navarra/ CIMA,IDISNA, CIBERONC,Pamplona, SPAIN.; Lahuerta JJ; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Madrid, Spain.; Martinez-Lopez J; Hematology Department, Hospital Universitario 12 de Octubre, CIBERONC, Madrid, Spain.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Walker BA; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Mavrommatis K; Celgene Corporation, San Francisco, CA.; Wardell CP; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Ashby TC; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Bauer M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Davies FE; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Rosenthal A; Cancer Research and Biostatistics, Seattle, WA.; Wang H; Cancer Research and Biostatistics, Seattle, WA.; Qu P; Cancer Research and Biostatistics, Seattle, WA.; Hoering A; Cancer Research and Biostatistics, Seattle, WA.; Samur M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Towfic F; Celgene Corporation, Summit, NJ.; Ortiz M; Celgene Institute of Translational Research Europe, Sevilla, Spain.; Flynt E; Celgene Corporation, Summit, NJ.; Yu Z; Celgene Corporation, Summit, NJ.; Yang Z; Celgene Corporation, Summit, NJ.; Rozelle D; Rancho BioSciences, San Diego, CA.; Obenauer J; Rancho BioSciences, San Diego, CA.; Trotter M; Celgene Institute of Translational Research Europe, Sevilla, Spain.; Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT.; Keats J; Translational Genomics Research Institute, Phoenix, AZ.; Bolli N; Department of Oncology, University of Milan, Milan, Italy.; Fulciniti M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Szalat R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Moreau P; Department of Hematology, University of Nantes, Nantes, France.; Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA.; Stewart AK; Department of Hematology, Mayo Clinic, Scottsdale, AZ.; Goldschmidt H; Department of Medicine V, Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.; Raab MS; Department of Medicine V, Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.; German Cancer Research Center, Heidelberg, Germany.; Einsele H; Department of Internal Medicine II, Wurzburg University, Wurzburg, Germany.; Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; San Miguel J; Centro Investigacion Medica Aplicada, Clinica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Oncología, Pamplona, Spain.; Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA.; Jackson GH; Department of Haematology, Newcastle University, Newcastle, United Kingdom.; Anderson KC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Avet-Loiseau H; Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé et de la Recherche Médicale U1037, Toulouse, France; and.; L'Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire, Toulouse, France.; Munshi N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Thakurta A; Celgene Corporation, Summit, NJ.; Morgan GJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
International Journal of Radiation Oncology, Biology, Physics (INT J RADIAT ONCOL BIOL PHYS), Feb2013; 85(2): 335-340. (6p)
검색 결과 제한하기
제한된 항목
[AR] San Miguel J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어